Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest update is out from Synairgen ( (GB:SNG) ).
TFG Asset Management UK LLP has significantly increased its holdings in Synairgen PLC, now controlling 86.881% of the company’s voting rights, up from 28.154%. This substantial acquisition could strengthen Synairgen’s market position by aligning with a major stakeholder, potentially influencing future business strategies and decisions.
More about Synairgen
Synairgen is a UK-based biotechnology company focused on developing treatments for respiratory diseases, including severe viral infections. The company specializes in drug discovery and development and aims to address unmet medical needs in the respiratory health market.
YTD Price Performance: -26.22%
Average Trading Volume: 780,904
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £9.99M
See more insights into SNG stock on TipRanks’ Stock Analysis page.
